Extraordinary Announcement

Gedeon Richter Plc. in order to comply with the regulations of the Act LXVII of 2019 on the encouragement of long-term shareholder engagement and modification of certain acts with the purpose of legal harmonization (hereinafter: Act), based upon Subsection (5) 25 of the Act, hereby discloses such product supply and product- and service purchase transactions the Company entered into with its subsidiaries - defined in point b) Section 24 of the Act - in 6 months to June 2021, which falls under the scope of the referred Act because of their aggregated amount:

PRODUCT SUPPLY TRANSACTIONS

Date of the

Aggregated amount

Name of the related party

of the transaction

transaction

HUFm

GEDEON RICHTER IBÉRICA, S.A,

6 Months to June 2021

8,215

GEDEON RICHTER PHARMA GmbH

6 Months to June 2021

8,109

GEDEON RICHTER - RUS JSC

6 Months to June 2021

24,547

GEDEON RICHTER USA INC.

6 Months to June 2021

5,522

GEDEON RICHTER ITALIA S.R.L.

6 Months to June 2021

4,245

PRODUCT- AND SERVICE PURCHASE TRANSACTIONS

Date of the

Aggregated amount

Name of the related party

of the transaction

transaction

HUFm

GEDEON RICHTER PHARMA GmbH

6 Months to June 2021

6,111

GEDEON RICHTER ROMANIA SA

6 Months to June 2021

4,512

GEDEON RICHTER POLSKA SP.Z.O.O

6 Months to June 2021

5,227

LLC GEDEON RICHTER FARMA

6 Months to June 2021

6,360

Gedeon Richter Plc. does not have such open transaction the individual disclosure of which is set out by the Act.

Budapest, 20 July 2021

Gedeon Richter Plc.

Attachments

  • Original document
  • Permalink

Disclaimer

Gedeon Richter plc published this content on 20 July 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 20 July 2021 11:51:10 UTC.